| Description | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | Stars |
| CF | 13 B | 12 | 2.3 | 11.78 | 33 | 45 | 21 | 41 | 24 | 5 | 3 |
| UAN | 996 M | -15 | 2.7 | 14.78 | 32 | 39 | 30 | 1031 | 28 | 6 | 4 |
| MOS | 7.5 B | 9.6 | 1.1 | 0.48 | 11 | 19 | 22 | 239 | 36 | 13 | 0 |
| NTR | 29 B | 15 | 1.4 | 1.29 | 13 | 20 | 12 | 2526 | 37 | 13 | 1 |
| ICL | 6.7 B | 12 | 1.4 | 0.37 | 12 | 17 | 5.7 | 1.7 | 43 | 17 | 0 |
| IPI | 340 M | -148 | 5.2 | 5.89 | 3.4 | 23 | -5.2 | 56 | 28 | 2 | |
| CTVA | 45 B | 20 | 1.6 | 3.83 | -10.0 | 21 | 12 | 56 | 29 | 0 | |
| BIOX | 95 M | 2.3 | 0.94 | 0.26 | 8.9 | 3.7 | -16 | 60 | 31 | 1 | |
| FMC | 1.7 B | 2.8 | 1.4 | 3.98 | -18 | 14 | -49 | 62 | 35 | 1 | |
| SMG | 3.1 B | 12 | 1.3 | 0.64 | -31 | 15 | -6.6 | 64 | 37 | 0 | |
| LVRO | 85 M | -1.6 | 0.95 | 4.38 | 0.17 | 1.2 | -13 | 74 | 51 | 0 | |
| SEED | 11 M | 0.43 | 0.32 | -34 | -67 | -21 | 88 | 74 | 0 |
| Total Records: 12. | Quotes | Help |
| © George Elgin | Questions or Comments | Data last Modified 12/06/25 |
| P/E | Current Ratio | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | |
| Best 10% | 2.7 | 33 | 39 | 30 | 2526 | |
| Best 20% | 2.8 | 2.3 | 32 | 23 | 22 | 1031 |
| Best 30% | 9.6 | 1.6 | 13 | 21 | 22 | 1031 |
| mean | 10 | 1.7 | 14 | 19 | 17 | 767 |
| median | 12 | 1.4 | 11 | 19 | 16 | 239 |
| tr mean | 10 | 1.7 | 14 | 19 | 17 | 767 |
| count | 8.0 | 12 | 8.0 | 11 | 6.0 | 5.0 |